There are several classes of oral diabetes medications available in the United States, including sulfonylureas, meglitinides, biguanides, glitazones, and alpha-glucosidase inhibitors. These different classes have various mechanisms of action, giving each class a unique potential for toxicity that necessitates a distinct approach to evaluation, treatment, and disposition of each class of drug. The practicing emergency physician must have an understanding of these differences to safely care for patients exposed to these medications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.emc.2007.02.010 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!